Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by itntdfon Dec 29, 2023 1:07pm
152 Views
Post# 35804204

RE:RE:Paid advertising most likely but good PR nevertheless

RE:RE:Paid advertising most likely but good PR neverthelesspancan made the oncolytics announcement around sept 26.  this article was "dated" december 29 but obviously did not make mention that pancan was cancelling further trials while they were doing a "strategic re-evaluation".

can find no mention of ANY strategic reevaluation in any pancan links.  the only mention of a strategic reevaluation was in oncy's press release.

that, together with no mention of andrew de, is just bizarre.

sent an email to oncy this morning asking about andrew de.  if he is gone, that is certainly not some type of "secret" which can not be disclosed.

looked at andrew's employment agreement when he was hired by oncy.  andrew's signature was witnessed by roshawn blunt who is andrew's wife.  ????  if andrew "left" oncy and went to one of her companies in any capacity, it would certainly raise some questions about oncy's proprietary information.

checked san diego federal court docket info to see if any action(s) by or against andrew de or involving oncy but got no hits.

could find absolutely nothing about andrew de post oncy if he is indeed in some capacity "post oncy".
<< Previous
Bullboard Posts
Next >>